Salt la conţinut

Oncologie

Riscurile şi incertitudinile transfuziei

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (se deschide o fereastră nouă)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Sursă‎: Surgery 2012;152(3):344-54.

Index‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (se deschide o fereastră nouă)

Perioperative blood transfusions promote pancreas cancer progression. (se deschide o fereastră nouă)

Benson D, Barnett CC Jr.

Sursă‎: J Surg Res 2011;166(2):275-9.

Index‎: PubMed 20828757

DOI‎: 10.1016/j.jss.2010.05.059

https://www.ncbi.nlm.nih.gov/pubmed/20828757 (se deschide o fereastră nouă)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (se deschide o fereastră nouă)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Sursă‎: Ann Med Surg (Lond) 2016;6:6-11.

Index‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (se deschide o fereastră nouă)

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. (se deschide o fereastră nouă)

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Sursă‎: Arch Intern Med 2008;168(21):2377-81.

Index‎: PubMed 19029504

DOI‎: 10.1001/archinte.168.21.2377

https://www.ncbi.nlm.nih.gov/pubmed/19029504 (se deschide o fereastră nouă)

Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. (se deschide o fereastră nouă)

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y.

Sursă‎: PLoS One 2013;8(5):e64261.

Index‎: PubMed 23741309

DOI‎: 10.1371/journal.pone.0064261

https://www.ncbi.nlm.nih.gov/pubmed/23741309 (se deschide o fereastră nouă)

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. (se deschide o fereastră nouă)

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC.

Sursă‎: J Surg Res 2009;153(1):114-20.

Index‎: PubMed 19201421

DOI‎: 10.1016/j.jss.2008.06.005

https://www.ncbi.nlm.nih.gov/pubmed/19201421 (se deschide o fereastră nouă)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (se deschide o fereastră nouă)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Sursă‎: Cancer Treat Rev 2016;46:1-8.

Index‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (se deschide o fereastră nouă)

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. (se deschide o fereastră nouă)

Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE.

Sursă‎: Dis Colon Rectum 2015;58(1):74-82.

Index‎: PubMed 25489697

DOI‎: 10.1097/DCR.0000000000000233

https://www.ncbi.nlm.nih.gov/pubmed/25489697 (se deschide o fereastră nouă)